Abstract
l-Glutamate is a neurotransmitter throughout the various levels of retinal neurons (photoreceptors, bipolar cells, ganglion cells) and acts at a range of ionotropic (iGlu) and metabotropic glutamate (mGlu) receptors to exert its physiological roles. A function unique to the retina can be ascribed to mGlu6 receptors, which are expressed only by ON bipolar cells at the sign-inverting synapse formed by photoreceptors. More conventional excitatory sign-conserving synapses utilizing iGlu receptors are formed at other locations in the retina. Over-activation of iGlu receptors (and especially NMDA receptors) is known to lead to excitotoxicity in the retina, as in other areas of the nervous system, and this may be associated with excessive neuronal Ca2+ influx. This excitotoxicity can be prevented or countered by iGlu receptor antagonists, both in vitro and in vivo. Furthermore, in some experimental models of retinal neurodegeneration, e.g., for glaucoma or ischemia, a number of different types of iGluR antagonists have been shown to be effective in a variety of species. In particular, the uncompetitive NMDA antagonist memantine has shown promise in experimental studies, but clinical trials to treat glaucoma with this drug have not had a successful outcome, possibly due to the unavailability of suitable markers of disease progression and heterogeneity of the disease in humans. It is thus important that further work is carried out so as to translate preclinical findings on neurodegeneration into successful clinical treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AMPA:
-
(S)-α-amino-3-hydroxy-5-methyl-4-iso-xazolepropionic acid
- EAAT:
-
Excitatory amino acid transporter
- L-AP4:
-
(APB) l-2-amino-4-phosphonobutyric acid
- mGlu:
-
Metabotropic glutamate
- NMDA:
-
N-methyl-d-aspartate
- RGC:
-
Retinal ganglion cell
References
Allergan Inc. (2008). Press release on Memantine Trials, Fourth Quarter Operating Results, Jan 30 2008. Press Release, http://agn.client.shareholder.com/releasedetail.cfm?ReleaseID=290764
Almasieh, M., Wilson, A. M., Morquette, B., Cueva Vargas, J. L., & Di Polo, A. (2012). The molecular basis of retinal ganglion cell death in glaucoma. Progress in Retinal and Eye Research, 31, 152–181.
Baltmr, A., Duggan, J., Nizari, S., Salt, T. E., & Cordeiro, M. F. (2010). Neuroprotection in glaucoma – Is there a future role? Experimental Eye Research, 91, 554–566.
Battaglia, G., Molinaro, G., Riozzi, B., Storto, M., Busceti, C. L., Spinsanti, P., Bucci, D., Di Liberto, V., Mudo, G., Corti, C., Corsi, M., Nicoletti, F., Belluardo, N., & Bruno, V. (2009). Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons. PloS One, 4, e6591.
Beart, P. M., & O’Shea, R. D. (2007). Transporters for L-glutamate: An update on their molecular pharmacology and pathological involvement. British Journal of Pharmacology, 150, 5–17.
Beraudi, A., Bruno, V., Battaglia, G., Biagioni, F., Rampello, L., Nicoletti, F., & Poli, A. (2007). Pharmacological activation of mGlu2/3 metabotropic glutamate receptors protects retinal neurons against anoxic damage in the goldfish Carassius auratus. Experimental Eye Research, 84, 544–552.
Bond, A., O’Neill, M. J., Hicks, C. A., Monn, J. A., & Lodge, D. (1998). Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. Neuroreport, 9, 1191–1193.
Bringmann, A., Pannicke, T., Biedermann, B., Francke, M., Iandiev, I., Grosche, J., Wiedemann, P., Albrecht, J., & Reichenbach, A. (2009). Role of retinal glial cells in neurotransmitter uptake and metabolism. Neurochemistry International, 54, 143–160.
Brooks, D. E., Garcia, G. A., Dreyer, E. B., Zurakowski, D., & Franco-Bourland, R. E. (1997). Vitreous body glutamate concentration in dogs with glaucoma. American Journal of Veterinary Research, 58, 864–867.
Bruno, V., Battaglia, G., Copani, A., D’Onofrio, M., Di Iorio, P., De Blasi, A., Melchiorri, D., Flor, P. J., & Nicoletti, F. (2001). Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. Journal of Cerebral Blood Flow and Metabolism, 21, 1013–1033.
Caraci, F., Battaglia, G., Bruno, V., Bosco, P., Carbonaro, V., Giuffrida, M. L., Drago, F., Sortino, M. A., Nicoletti, F., & Copani, A. (2009). TGF-beta1 pathway as a new target for neuroprotection in Alzheimer’s disease. CNS Neuroscience and Therapeutics, 17(4), 237–249.
Carter-Dawson, L., Crawford, M. L., Harwerth, R. S., Smith, E. L., 3rd, Feldman, R., Shen, F. F., Mitchell, C. K., & Whitetree, A. (2002). Vitreal glutamate concentration in monkeys with experimental glaucoma. Investigative Ophthalmology & Visual Science, 43, 2633–2637.
Casson, R. J. (2006). Possible role of excitotoxicity in the pathogenesis of glaucoma. Clinical & Experimental Ophthalmology, 34, 54–63.
Chaudhary, P., Ahmed, F., & Sharma, S. C. (1998). MK801-a neuroprotectant in rat hypertensive eyes. Brain Research, 792, 154–158.
Choi, D. W. (1988). Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1, 623–634.
Choi, D. W. (1992). Excitotoxic cell death. Journal of Neurobiology, 23, 1261–1276.
Copani, A., Bruno, V., Battaglia, G., Leanza, G., Pellitteri, R., Russo, A., Stanzani, S., & Nicoletti, F. (1995). Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. Molecular Pharmacology, 47, 890–897.
Cordeiro, M. F., Guo, L., Coxon, K. M., Duggan, J., Nizari, S., Normando, E. M., Sensi, S. L., Sillito, A. M., Fitzke, F. W., Salt, T. E., & Moss, S. E. (2010). Imaging multiple phases of neurodegeneration:a novel approach to assessing cell death in vivo. Cell Death and Disease, 1, e3.
Corti, C., Battaglia, G., Molinaro, G., Riozzi, B., Pittaluga, A., Corsi, M., Mugnaini, M., Nicoletti, F., & Bruno, V. (2007). The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection. The Journal of Neuroscience, 27, 8297–8308.
Curtis, D. R., & Watkins, J. C. (1963). Acidic amino acids with strong excitatory actions on mammalian neurones. The Journal of Physiology, 166, 1–14.
Dalton, R. (2001). Private investigations. Nature, 411, 129–130.
Danysz, W., & Parsons, C. G. (1998). Glycine and N-Methyl-D-Aspartate receptors: Physiological significance and possible therapeutic applications. Pharmacological Reviews, 50, 597–664.
Doble, A. (1999). The role of excitotoxicity in neurodegenerative disease: Implications for therapy. Pharmacology & Therapeutics, 81, 163–221.
Dreyer, E. B., Zurakowski, D., Schumer, R. A., Podos, S. M., & Lipton, S. A. (1996). Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Archives of Ophthalmology, 114, 299–305.
Dryja, T. P., McGee, T. L., Berson, E. L., Fishman, G. A., Sandberg, M. A., Alexander, K. R., Derlacki, D. J., & Rajagopalan, A. S. (2005). Night blindness and abnormal cone electroretinogram ON responses in patients with mutations in the GRM6 gene encoding mGluR6. Proceedings of the National Academy of Sciences of the United States of America, 102, 4884–4889.
Dyka, F. M., May, C. A., & Enz, R. (2004). Metabotropic glutamate receptors are differentially regulated under elevated intraocular pressure. Journal of Neurochemistry, 90, 190–202.
Fletcher, E. L., Hack, I., Brandstatter, J. H., & Wassle, H. (2000). Synaptic localization of NMDA receptor subunits in the rat retina. The Journal of Comparative Neurology, 420, 98–112.
Furuya, T., Pan, Z., & Kashiwagi, K. (2012). Role of retinal glial cell glutamate transporters in retinal ganglion cell survival following stimulation of NMDA receptor. Current Eye Research, 37, 170–178.
Fyk-Kolodziej, B., Qin, P., Dzhagaryan, A., & Pourcho, R. G. (2004). Differential cellular and subcellular distribution of glutamate transporters in the cat retina. Visual Neuroscience, 21, 551–565.
Greenfield, D. S., Girkin, C., & Kwon, Y. H. (2005). Memantine and progressive glaucoma. Journal of Glaucoma, 14, 84–86.
Guo, L., Salt, T. E., Maass, A., Luong, V., Moss, S. E., Fitzke, F. W., & Cordeiro, M. F. (2006). Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. Investigative Ophthalmology & Visual Science, 47, 626–633.
Gustafson, E. C., Stevens, E. R., Wolosker, H., & Miller, R. F. (2007). Endogenous D-Serine contributes to NMDA-Receptor-Mediated light-evoked responses in the vertebrate retina. Journal of Neurophysiology, 98, 122–130.
Had-Aissouni, L. (2012). Toward a new role for plasma membrane sodium-dependent glutamate transporters of astrocytes: Maintenance of antioxidant defenses beyond extracellular glutamate clearance. Amino Acids, 42, 181–197.
Harada, T., Harada, C., Nakamura, K., Quah, H.-M. A., Okumura, A., Namekata, K., Saeki, T., Aihara, M., Yoshida, H., Mitani, A., & Tanaka, K. (2007). The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. The Journal of Clinical Investigation, 117, 1763–1770.
Hare, W. A., WoldeMussie, E., Lai, R. K., Ton, H., Ruiz, G., Chun, T., & Wheeler, L. (2004). Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures. Investigative Ophthalmology & Visual Science, 45, 2625–2639.
Hartveit, E., Brandstatter, J. H., Enz, R., & Wässle, H. (1995). Expression of the mRNA of seven metabotropic glutamate receptors (mGluR1 to 7) in the rat retina. An in situ hybridization study on tissue sections and isolated cells. The European Journal of Neuroscience, 7, 1472–1483.
Kalbaugh, T. L., Zhang, J., & Diamond, J. S. (2009). Coagonist release modulates NMDA receptor subtype contributions at synaptic inputs to retinal ganglion cells. The Journal of Neuroscience, 29, 1469–1479.
Kapin, M. A., Doshi, R., Scatton, B., DeSantis, L. M., & Chandler, M. L. (1999). Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia. Investigative Ophthalmology and Visual Science, 40, 1177–1182.
Kim, D. Y., Kim, S. H., Choi, H. B., C-k, M., & Gwag, B. J. (2001). High abundance of GluR1 mRNA and reduced Q/R editing of GluR2 mRNA in individual NADPH-Diaphorase neurons. Molecular and Cellular Neuroscience, 17, 1025–1033.
Kim, T. W., Kim, D. M., Park, K. H., & Kim, H. (2002). Neuroprotective effect of memantine in a rabbit model of optic nerve ischemia. Korean Journal of Ophthalmology: KJO, 16, 1–7.
Kobayashi, K. (1967). Studies on ERG, EOG and histological findings of the rabbit retinae treated with sodium L-glutamate. Nihon Ganka Gakkai Zasshi, 71, 1458–1465.
Koulen, P., & Brandstatter, J. H. (2002). Pre- and postsynaptic sites of action of mGluR8a in the mammalian retina. Investigative Ophthalmology and Visual Science, 43, 1933–1940.
Koulen, P., Malitschek, B., Kuhn, R., Wassle, H., & Brandstatter, J. H. (1996). Group II and Group III metabotropic glutamate receptors in the rat retina: Distributions and developmental expression patterns. The European Journal of Neuroscience, 8, 2177–2187.
Koulen, P., Kuhn, R., Wassle, H., & Brandstatter, J. H. (1997). Group I metabotropic glutamate receptors Mglur1 alpha and Mglur5a: Localization in both synaptic layers of the rat retina. The Journal of Neuroscience, 17, 2200–2211.
Kugler, P., & Beyer, A. (2003). Expression of glutamate transporters in human and rat retina and rat optic nerve. Histochemistry and Cell Biology, 120, 199–212.
Kwon, Y. H., Rickman, D. W., Baruah, S., Zimmerman, M. B., Kim, C. S., Boldt, H. C., Russell, S. R., & Hayreh, S. S. (2005). Vitreous and retinal amino acid concentrations in experimental central retinal artery occlusion in the primate. Eye, 19, 455–463.
Lebrun-Julien, F., Duplan, L., Pernet, V., Osswald, I., Sapieha, P., Bourgeois, P., Dickson, K., Bowie, D., Barker, P. A., & Di Polo, A. (2009). Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism. The Journal of Neuroscience, 29, 5536–5545.
Lee, A., Anderson, A. R., Barnett, N. L., Stevens, M. G., & Pow, D. V. (2012). Alternate splicing and expression of the glutamate transporter EAAT5 in the rat retina. Gene, 506, 283–288.
Lipton, S. A. (1993). Prospects for clinically tolerated NMDA antagonists: Open-channel blockers and alternative redox states of nitric oxide. Trends in Neurosciences, 16, 527–532.
Lipton, S. A. (2004). Paradigm shift in NMDA receptor antagonist drug development: Molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer’s disease and other neurologic disorders. Journal of Alzheimer's Disease, 6, S61–S74.
Lodge, D. (2009). The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature. Neuropharmacology, 56, 6–21.
Low, C. M., & Wee, K. S. L. (2010). New Insights into the Not-So-New NR3 Subunits of N-Methyl-D-aspartate Receptor: Localization, structure, and function. Molecular Pharmacology, 78, 1–11.
Lucas, D. R., & Newhouse, J. P. (1957). The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Archives of Ophthalmology, 58, 193–201.
Lukasiewicz, P. D. (2009). Retinal pharmacology: Inner retinal layers. In R. S. Larry (Ed.), Encyclopedia of neuroscience (pp. 255–261). Oxford: Academic Press.
Luo, T., Wu, W. H., & Chen, B. S. (2011). NMDA receptor signaling: Death or survival? Frontiers in Biology, 6, 468–476.
Meldrum, B. S. (2000). Glutamate as a neurotransmitter in the brain: Review of physiology and pathology. The Journal of Nutrition, 130, 1007S–1015S.
Morgans, C. W., Brown, R. L., & Duvoisin, R. M. (2010). TRPM1: The endpoint of the mGluR6 signal transduction cascade in retinal ON-bipolar cells. BioEssays, 32, 609–614.
Nakajima, Y., Iwakabe, H., Akazawa, C., Nawa, H., Shigemoto, R., Mizuno, N., & Nakanishi, S. (1993). Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate. The Journal of Biological Chemistry, 268, 11868–11873.
Nakanishi, N., Tu, S., Shin, Y., Cui, J., Kurokawa, T., Zhang, D., Chen, H. S., Tong, G., & Lipton, S. A. (2009). Neuroprotection by the NR3A subunit of the NMDA receptor. The Journal of Neuroscience, 29, 5260–5265.
Ngomba, R. T., Moyanova, S. G., Mastroiacovo, F., Kortenska, L. V., Mitreva, R. G., Fardone, E., Santolini, I., Sobrado, M., Battaglia, G., Bruno, V., & Nicoletti, F. (2011). Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage. Journal of Cerebral Blood Flow and Metabolism, 31, 1107–1118.
Niswender, C. M., & Conn, P. J. (2010). Metabotropic glutamate receptors: Physiology, pharmacology, and disease. Annual Review of Pharmacology, 50, 295–322.
Osborne, N. N. (2009). Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned. Acta Ophthalmologica, 87, 450–454.
Parsons, C. G., Danysz, W., & Quack, G. (1999). Memantine is a clinically well tolerated N-methyl–aspartate (NMDA) receptor antagonist–a review of preclinical data. Neuropharmacology, 38, 735–767.
Pignataro, L., Sitaramayya, A., Finnemann, S. C., & Sarthy, V. P. (2005). Nonsynaptic localization of the excitatory amino acid transporter 4 in photoreceptors. Molecular and Cellular Neurosciences, 28, 440–451.
Quraishi, S., Gayet, J., Morgans, C. W., & Duvoisin, R. M. (2007). Distribution of group-III metabotropic glutamate receptors in the retina. The Journal of Comparative Neurology, 501, 931–943.
Quraishi, S., Reed, B. T., Duvoisin, R. M., & Taylor, W. R. (2010). Selective activation of mGluR8 receptors modulates retinal ganglion cell light responses. Neuroscience, 166, 935–941.
Rauen, T., Taylor, W. R., Kuhlbrodt, K., & Wiessner, M. (1997). High-affinity glutamate transporters in the rat retina: A major role of the glial glutamate transporter GLAST-1 in transmitter clearance. Cell and Tissue Research, 291, 19–31.
Salt, T. E., & Cordeiro, M. F. (2006). Glutamate excitotoxicity in glaucoma: Throwing the baby out with the bathwater? Eye, 20, 730–731.
Schuettauf, F., Naskar, R., Vorwerk, C. K., Zurakowski, D., & Dreyer, E. B. (2000). Ganglion cell loss after optic nerve crush mediated through AMPA-kainate and NMDA receptors. Investigative Ophthalmology and Visual Science, 41, 4313–4316.
Shigeri, Y., Seal, R. P., & Shimamoto, K. (2004). Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Research Reviews, 45, 250–265.
Slaughter, M. M. (2010). Glutamate receptors in retina. In A. D. Darlene (Ed.), Encyclopedia of the eye (pp. 222–226). Oxford: Academic Press.
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010). Glutamate receptor ion channels: Structure, regulation, and function. Pharmacological Reviews, 62, 405–496.
Ward, M. M., Jobling, A. I., Puthussery, T., Foster, L. E., & Fletcher, E. L. (2004). Localization and expression of the glutamate transporter, excitatory amino acid transporter 4, within astrocytes of the rat retina. Cell and Tissue Research, 315, 305–310.
Wassle, H. (2004). Parallel processing in the mammalian retina. Nature Reviews Neuroscience, 5, 747–757.
Watkins, J. C., & Evans, R. H. (1981). Excitatory amino acid transmitters. Annual Review of Pharmacology, 21, 165–204.
Waxman, E. A., & Lynch, D. R. (2005). N-methyl-D-aspartate receptor subtypes: Multiple roles in excitotoxicity and neurological disease. The Neuroscientist, 11, 37–49.
Weinreb, R. N., & Khaw, P. T. (2004). Primary open-angle glaucoma. Lancet, 363, 1711–1720.
Wersinger, E., Schwab, Y., Sahel, J. A., Rendon, A., Pow, D. V., Picaud, S., & Roux, M. J. (2006). The glutamate transporter EAAT5 works as a presynaptic receptor in mouse rod bipolar cells. Journal of Physiology (London), 577, 221–234.
WoldeMussie, E., Yoles, E., Schwartz, M., Ruiz, G., & Wheeler, L. A. (2002). Neuroprotective effect of memantine in different retinal injury models in rats. Journal of Glaucoma, 11, 474–480.
Yucel, Y. H., Gupta, N., Zhang, Q., Mizisin, A. P., Kalichman, M. W., & Weinreb, R. N. (2006). Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Archives of Ophthalmology, 124, 217–225.
Zeitz, C., van Genderen, M., Neidhardt, J., Luhmann, U. F., Hoeben, F., Forster, U., Wycisk, K., Matyas, G., Hoyng, C. B., Riemslag, F., Meire, F., Cremers, F. P., & Berger, W. (2005). Mutations in GRM6 cause autosomal recessive congenital stationary night blindness with a distinctive scotopic 15-Hz flicker electroretinogram. Investigative Ophthalmology & Visual Science, 46, 4328–4335.
Zeitz, C., Forster, U., Neidhardt, J., Feil, S., Kalin, S., Leifert, D., Flor, P. J., & Berger, W. (2007). Night blindness-associated mutations in the ligand-binding, cysteine-rich, and intracellular domains of the metabotropic glutamate receptor 6 abolish protein trafficking. Human Mutation, 28, 771–780.
Zhang, J., & Diamond, J. S. (2009). Subunit- and pathway-specific localization of NMDA receptors and scaffolding proteins at ganglion cell synapses in rat retina. The Journal of Neuroscience, 29, 4274–4286.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Salt, T.E. (2014). Glutamate and Neurodegeneration in the Retina. In: Kostrzewa, R. (eds) Handbook of Neurotoxicity. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5836-4_172
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5836-4_172
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5835-7
Online ISBN: 978-1-4614-5836-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences